Effect of long term treatment with oxitropium bromide on airway secretion in chronic bronchitis and diffuse panbronchiolitis.

BACKGROUND--Anticholinergic bronchodilator drugs improve lung function in chronic bronchitis but less is known of their effects on the volume and physical properties of sputum in conditions associated with excessive airway secretions. This study examines the effects of the regular use of oxitropium bromide in such patients. METHODS--The study was conducted in a parallel, double blind, placebo controlled fashion. Patients were divided into two groups: the first group (n = 17) received oxitropium bromide from a metered dose inhaler (two puffs three times daily; 100 micrograms/puff) for eight weeks, and the second group (n = 16) received placebo. Lung function was measured as forced expiratory volume in one second (FEV1) and vital capacity. In evaluating airway secretion, daily amount of expectorated sputum, percentage solid composition, viscoelastic properties including elastic modulus and dynamic viscosity, and sputum microbiology were determined. RESULTS--Oxitropium bromide increased FEV1 and decreased the mean (SE) sputum production from 61(4) to 42(3) g/day after treatment, whereas placebo had no effect. Bacterial density and sputum flora were unchanged, but solid composition and elastic modulus increased from 2.52(0.43)% to 3.12(0.34)%, and 68(12) dyne/cm2, respectively, in the group taking oxitropium bromide. CONCLUSIONS--Regular treatment with oxitropium bromide not only improves airflow limitation but also reduces sputum production, probably through the inhibition of both mucus secretion and water transport, the latter component being predominant.

[1]  R. Hard,et al.  Autoregulation of beat frequency in respiratory ciliated cells. Demonstration by viscous loading. , 1991, The American review of respiratory disease.

[2]  N. Gross.  The influence of anticholinergic agents on treatment for bronchitis and emphysema. , 1991, The American journal of medicine.

[3]  H. Kuo,et al.  Neural control of goblet cell secretion in guinea pig airways. , 1990, The American journal of physiology.

[4]  S. Kudoh,et al.  Analysis of HLA antigens in patients with diffuse panbronchiolitis. , 1990, The American review of respiratory disease.

[5]  The evolving regulatory environment and bedside metabolic monitoring of the acute care patient. , 1990, Chest.

[6]  W. Warwick,et al.  Reduction of sputum Pseudomonas aeruginosa density by antibiotics improves lung function in cystic fibrosis more than do bronchodilators and chest physiotherapy alone. , 1990, The American review of respiratory disease.

[7]  M. King,et al.  Collection and analysis of respiratory mucus from subjects without lung disease. , 1990, The American review of respiratory disease.

[8]  A. Wanner.  The role of mucus in chronic obstructive pulmonary disease. , 1990, Chest.

[9]  J. Shelhamer,et al.  Pathogenesis of airway mucus hypersecretion. , 1990, The Journal of allergy and clinical immunology.

[10]  D. Pavia,et al.  Effect of four-week treatment with oxitropium bromide on lung mucociliary clearance in patients with chronic bronchitis or asthma. , 1989, Respiration; international review of thoracic diseases.

[11]  T. Miyata,et al.  Effects of anticholinergic bronchodilators on mucociliary transport and airway secretion. , 1989, Japanese journal of pharmacology.

[12]  N. Anthonisen,et al.  Prognosis in chronic obstructive pulmonary disease. , 1990, The American review of respiratory disease.

[13]  P. Barnes,et al.  Reduction of nocturnal asthma by an inhaled anticholinergic drug. , 1986, Chest.

[14]  F. Kauffmann,et al.  Is respiratory mucus hypersecretion really an innocent disorder? A 22-year mortality survey of 1,061 working men. , 1986, The American review of respiratory disease.

[15]  E. Peel,et al.  A dose response study of oxitropium bromide in chronic bronchitis. , 1984, Thorax.

[16]  F. Speizer,et al.  The relevance in adults of air-flow obstruction, but not of mucus hypersecretion, to mortality from chronic lung disease. Results from 20 years of prospective observation. , 1983, The American review of respiratory disease.

[17]  Nadel Ja.  Neural control of airway submucosal gland secretion. , 1983 .

[18]  J. Nadel.  Neural control of airway submucosal gland secretion. , 1983, European journal of respiratory diseases. Supplement.

[19]  S. Kira,et al.  Diffuse Panbronchiolitis: A Disease of the Transitional Zone of the Lung , 1983 .

[20]  D. Wolf,et al.  Effect of nondialyzable solids concentration and viscoelasticity on ciliary transport of tracheal mucus. , 1977, The American review of respiratory disease.

[21]  M. Segal.  Therapeutic aerosols. , 1977, Comprehensive therapy.

[22]  J. Nadel,et al.  Effect of acetylcholine on Cl- and Na+ fluxes across dog tracheal epithelium in vitro. , 1976, The American journal of physiology.

[23]  T. Clark,et al.  Effect of atropine on sputum production. , 1975, Thorax.